Laurie Miller Turner, PA
Physician Assistant · Florence, SCNPI 1467520213
Payments from drug & device makers
Across 332 payments — averaging $16.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$994
- AstraZeneca$540
- Novo Nordisk$482
- Lilly USA, LLC$339
- Amgen$330
- GSK$328
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,333100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 61 | $994 |
| AstraZeneca | 30 | $540 |
| Novo Nordisk | 32 | $482 |
| Lilly USA, LLC | 28 | $339 |
| Amgen | 19 | $330 |
| GSK | 17 | $328 |
| Abbott | 20 | $314 |
| Boehringer Ingelheim | 15 | $243 |
| Bayer | 12 | $216 |
| Pfizer | 11 | $168 |
| Esperion Therapeutics, Inc. | 9 | $135 |
| Sanofi-aventis U.S. LLC | 8 | $132 |
| Novartis | 8 | $130 |
| Amarin Pharma, Inc. | 9 | $130 |
| Merck | 6 | $95 |
| Biohaven Pharmaceuticals, Inc. | 5 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $81 |
| Kowa Pharmaceuticals America, Inc. | 5 | $73 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $57 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $52 |
| Phathom Pharmaceuticals, Inc. | 3 | $46 |
| Idorsia Pharmaceuticals US Inc | 3 | $42 |
| Shield Therapeutics Inc | 2 | $37 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $37 |
| Exact Sciences | 2 | $35 |
| Seqirus USA Inc | 2 | $31 |
| Boston Scientific | 1 | $22 |
| Johnson & Johnson | 1 | $19 |
| Nevro Corp. | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Eyevance Pharmaceuticals LLC | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
| Vistapharm, Inc. | 1 | $13 |
How this compares
$5,333 in reported general payments places this provider in the 90th percentile of 1,852 physician assistant providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 152 | $161,340 |
| JardianceEmpagliflozin | 77 | $72,620 |
| JanuviaSitagliptin Phosphate | 52 | $52,858 |
| OzempicSemaglutide | 44 | $46,385 |
| FarxigaDapagliflozin Propanediol | 50 | $40,049 |
| EliquisApixaban | 30 | $33,372 |
| Repatha SureclickEvolocumab | 21 | $17,029 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $13,312 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $12,258 |
| LivaloPitavastatin Calcium | 13 | $10,568 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $8,638 |
| Diclofenac Sodium | 102 | $8,203 |
| LinzessLinaclotide | 13 | $7,702 |
| SynthroidLevothyroxine Sodium | 72 | $6,235 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 34 | $5,968 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $339 | $161,340152 claims |
| Boehringer IngelheimJardiance | $243 | $72,62077 claims |
| MerckJanuvia | $95 | $52,85852 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $540 | $48,68764 claims |
| Novo NordiskOzempic | $482 | $46,38544 claims |
| PfizerEliquis | $168 | $33,37230 claims |
| AbbVieLinzess, Synthroid | $994 | $13,93785 claims |
| GSKTrelegy Ellipta | $328 | $12,25817 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $73 | $10,56813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,852 physician assistant providers in South Carolina.
Other physician assistant in Florence
- Maggie BoykinFlorence$14K
- Chelsea AtkinsonFlorence$13K
- Abigail HamFlorence$10K
- Benjamin AddyWest Columbia$377K
- Michael OvercashCharleston$210K
- Allison LesterMt Pleasant$163K
- Nicole KeeterFort Mill$129K
- William YoungGreenville$117K
- Stephanie DavisAnderson$78K
- Vicki RobertsWest Columbia$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.